BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 31/08/1994

National Institutes of Health to Grant Exclusive License for Calanolide Antiviral Compounds

The National Institutes of Health is considering granting an exclusive worldwide license to practice a patented antiviral compound invention to MediChem Research, Inc., with the potential to be limited to treating AIDS, and is seeking public comment within 60 days.

Source: Federal Register — Health and Human ServicesOpen original release →